Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Mani

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Thrombosis Journal|November 2, 2013
Main considerable factors for correct laboratory test interpretation under DOA treatmentHelen Mani, Edelgard Lindhoff-Last
Drug Design, Development and Therapy|June 28, 2014
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectivenessHelen Mani, Edelgard Lindhoff-Last
Clinical Chemistry and Laboratory Medicine|December 24, 2010
Platelet function testing in hirudin and BAPA anticoagulated bloodHelen Mani, Mirna Hellis, Edelgard Lindhoff-Last
Journal of Thrombosis and Thrombolysis|March 21, 2013
Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitationsHelen Mani, Alexander Kasper, Edelgard Lindhoff-Last
Thrombosis and Haemostasis|June 10, 2011
Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration timeHelen Mani, Christian Hesse, Gertrud Stratmann, et al.
Thrombosis and Haemostasis|November 10, 2012
Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditionsHelen Mani, Christian Hesse, Gertrud Stratmann, et al.
Platelets|August 25, 2006
Response to aspirin and clopidogrel monitored with different platelet function methodsHelen Mani, Birgit Linnemann, Beate Luxembourg, et al.
Annals of Hematology|February 28, 2009
Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-upBirgit Linnemann, Stephanie Prochnow, Helen Mani, et al.
Annals of Hematology|January 6, 2010
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2YBirgit Linnemann, Jan Schwonberg, Andreas R Rechner, et al.
Atherosclerosis|February 16, 2010
Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive diseaseBirgit Linnemann, Jan Schwonberg, Stefan W Toennes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Thrombosis Journal|November 2, 2013
Main considerable factors for correct laboratory test interpretation under DOA treatmentHelen Mani, Edelgard Lindhoff-Last
Drug Design, Development and Therapy|June 28, 2014
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectivenessHelen Mani, Edelgard Lindhoff-Last
Clinical Chemistry and Laboratory Medicine|December 24, 2010
Platelet function testing in hirudin and BAPA anticoagulated bloodHelen Mani, Mirna Hellis, Edelgard Lindhoff-Last
Journal of Thrombosis and Thrombolysis|March 21, 2013
Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitationsHelen Mani, Alexander Kasper, Edelgard Lindhoff-Last
Thrombosis and Haemostasis|June 10, 2011
Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration timeHelen Mani, Christian Hesse, Gertrud Stratmann, et al.
Thrombosis and Haemostasis|November 10, 2012
Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditionsHelen Mani, Christian Hesse, Gertrud Stratmann, et al.
Platelets|August 25, 2006
Response to aspirin and clopidogrel monitored with different platelet function methodsHelen Mani, Birgit Linnemann, Beate Luxembourg, et al.
Annals of Hematology|February 28, 2009
Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-upBirgit Linnemann, Stephanie Prochnow, Helen Mani, et al.
Annals of Hematology|January 6, 2010
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2YBirgit Linnemann, Jan Schwonberg, Andreas R Rechner, et al.
Atherosclerosis|February 16, 2010
Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive diseaseBirgit Linnemann, Jan Schwonberg, Stefan W Toennes, et al.
Pageof 2